Promakhos Therapeutics is developing novel bacterial therapies to treat inflammatory disorders like Crohn's disease, type 1 diabetes, and multiple sclerosis. Learn more about our innovative approach.
Promakhos Therapeutics develops curative therapies for chronic inflammatory diseases such as Crohn's disease, multiple sclerosis, and ankylosing spondylitis by restoring immune system function, allowing the body to control inflammation and heal. Promakhos Therapeutics takes a revolutionary approach that focuses on restoring immune balance rather than suppressing it, offering a more sustainable and effective treatment.
This product aims to help treat patients with chronic inflammatory diseases such as Crohn's disease and multiple sclerosis and help them regain their quality of life.
